SCHEMBL1012355

SCHEMBL1012355

CCCCCCCCCCCCCCCCCCc1cc(O)cc(C(=O)O)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.56
PTGS2 P35354 5/20 0.56
KAT8 Q9H7Z6 4/20 0.51
PPARA Q07869 2/20 0.51
PTGES O14684 1/20 0.49
TOP2A P11388 1/20 0.49
PTPN1 P18031 2/20 0.48
BID P55957 3/20 0.48
MCL1 Q07820 3/20 0.48
BCL2L1 Q07817 2/20 0.48
BAK1 Q16611 2/20 0.48
PPARG P37231 1/20 0.48
EP300 Q09472 1/20 0.48
KAT2A Q92830 1/20 0.48
KAT2B Q92831 1/20 0.48
KAT5 Q92993 1/20 0.48
SAE1 Q9UBE0 1/20 0.48
MEN1 O00255 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39883 0.93 GABRP (0.49) ALOX5PTGS2KAT8PPARAPTGES
SCHEMBL40166 0.86 PTPN1 (0.59) ALOX5PTGS2PTPN1MCL1PTPN11
SCHEMBL334415 0.86 KAT8 (0.50) ALOX5PTGS2KAT8PPARABID
SCHEMBL9303706 0.86 KAT8 (0.61) ALOX5PTGS2KAT8PPARABID
SCHEMBL7780121 0.86 KAT8 (0.61) ALOX5PTGS2KAT8PPARABID
SCHEMBL9955366 0.86 KAT8 (0.61) ALOX5PTGS2KAT8PPARABID
SCHEMBL9324615 0.86 KAT8 (0.50) ALOX5PTGS2KAT8PPARABID
SCHEMBL9500875 0.86 KAT8 (0.50) ALOX5PTGS2KAT8PPARABID
SCHEMBL7781047 0.86 KAT8 (0.50) ALOX5PTGS2KAT8PPARABID
SCHEMBL3220998 0.86 KAT8 (0.61) ALOX5PTGS2KAT8PPARABID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8344103-B2 Compatible-multiphase organic solvent system JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2013-01-01 US disclosed
EP-1426101-B1 COMPATIBLE-MULTIPHASE ORGANIC SOLVENT SYSTEM JAPAN SCIENCE & TECH AGENCY (JP) 2011-01-05 EP disclosed
US-20040214989-A1 Compatible-multiphase organic solvent system JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2004-10-28 US disclosed
EP-1426101-A1 COMPATIBLE-MULTIPHASE ORGANIC SOLVENT SYSTEM Japan Science and Technology Agency (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214989-A1 Compatible-multiphase organic solvent system FAU, OSTC, OTC ALOX5 1277/4885PTGS2 1506/4885KAT8 2757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.